5 Diagnostics and Pathology Labs Penny Stocks in India Investors Are Tracking for 2027

Investors tracking diagnostics and pathology labs penny stocks in India 2027 are looking at a mix of legacy names and smaller diagnostics and pathology labs players still trading under Rs 100 a share. Nephro Care India Ltd. and Sunil Healthcare Ltd. anchor this list by market cap, while smaller names such as Invicta Diagnostic Ltd. remain firmly in penny-stock territory.

India's diagnostics and pathology sector has grown with rising health awareness and preventive testing demand, but several smaller diagnostic chains and specialty clinics beyond the large national lab networks trade at low absolute prices, reflecting regional concentration and smaller scale than the branded diagnostic chains.

This article lists 5 diagnostics and pathology labs stocks worth tracking for 2027, along with their current price, market capitalisation, valuation ratios and the key risks each one carries.

Click Here – Get Free Investment Predictions

5 Best Diagnostics and Pathology Labs Penny Stocks in India for 2027

The table below lists these diagnostics and pathology labs penny stocks along with their current market price, market capitalisation, PE ratio, ROE and debt-to-equity ratio. 52-week trading range is not listed here; check the Univest app for live charting and technical levels.

Stock Name	CMP (Rs)	Market Cap (Rs Cr)	PE Ratio	ROE	Debt/Equity
Nephro Care India Ltd.	92.55	158.00	28.11	5.93%	0.00
Sunil Healthcare Ltd.	74.99	75.00	21.18	5.76%	0.80
Modern Diagnostic and Research Centre Ltd.	84.0	125.00	Loss	8.97%	0.63
Star Imaging and Path Lab Ltd.	78.49	142.00	7.38	16.61%	0.18
Invicta Diagnostic Ltd.	65.1	82.00	16.78	9.83%	0.07

Disclaimer: The stocks listed above are for educational purposes only and are not buy recommendations. Verify all figures independently and consult a SEBI-registered advisor before investing.

1. Nephro Care India Ltd.

CMP: Rs 92.55 | Market Cap: Rs 158.00 Cr

Nephro Care India Ltd. is the largest name on this list, a dialysis and nephrology care company with zero net debt. The stock trades at a PE of 28.11, with an ROE of 5.93% and a debt-to-equity ratio of 0.00.

2. Sunil Healthcare Ltd.

CMP: Rs 74.99 | Market Cap: Rs 75.00 Cr

Sunil Healthcare Ltd. is a healthcare and pharma packaging company trading below the sector PE. The stock trades at a PE of 21.18, with an ROE of 5.76% and a debt-to-equity ratio of 0.80.

3. Modern Diagnostic and Research Centre Ltd.

CMP: Rs 84.0 | Market Cap: Rs 125.00 Cr

Modern Diagnostic and Research Centre Ltd. is a diagnostics centre chain with no meaningful PE due to a small reported EPS. The stock trades at no meaningful PE (loss-making), with an ROE of 8.97% and a debt-to-equity ratio of 0.63.

ALSO READ: Top Multibagger Penny Stocks

4. Star Imaging and Path Lab Ltd.

CMP: Rs 78.49 | Market Cap: Rs 142.00 Cr

Star Imaging and Path Lab Ltd. is an imaging and pathology lab chain trading at the lowest PE on this list with strong ROE. The stock trades at a PE of 7.38, with an ROE of 16.61% and a debt-to-equity ratio of 0.18.

5. Invicta Diagnostic Ltd.

CMP: Rs 65.1 | Market Cap: Rs 82.00 Cr

Invicta Diagnostic Ltd. is a small diagnostics company trading below the sector PE with very low debt. The stock trades at a PE of 16.78, with an ROE of 9.83% and a debt-to-equity ratio of 0.07.

Download the Univest iOS App or Univest Android App to track live prices and research on diagnostics and pathology labs penny stocks and other sector names.

What Are Diagnostics and Pathology Labs Penny Stocks?

Diagnostics and Pathology Labs penny stocks are shares of companies operating in the diagnostics and pathology labs sector that trade at a low absolute price, usually under Rs 100, and often carry a small or micro market capitalisation. They give retail investors an inexpensive way to participate in the sector, but the low price also means wide daily swings, thin liquidity in some cases and, for several names on this list, negative or inconsistent earnings. Diagnostics and Pathology Labs penny stocks should be treated as a small, high-risk slice of a diversified portfolio rather than a core holding.

India's Diagnostics and Pathology Labs Sector: 2027 Overview

India's diagnostics and pathology sector has grown with rising health awareness and preventive testing demand, but several smaller diagnostic chains and specialty clinics beyond the large national lab networks trade at low absolute prices, reflecting regional concentration and smaller scale than the branded diagnostic chains.

For listed companies in this space, the gap between the largest and smallest players is stark: the sector's bigger names carry institutional coverage, steadier cash flows and lower promoter risk, while smaller and micro-cap names such as Nephro Care India, Sunil Healthcare, Modern Diagnostic and Research Centre depend far more on order wins, working-capital cycles and, in some cases, one-off asset sales or restructuring to move the needle on earnings. This gap matters for penny stock investors specifically, since a stock re-rating on a single quarter's results can reverse just as quickly once that quarter passes. Tracking promoter shareholding trends, debt reduction and revenue consistency over several quarters, rather than reacting to one sharp price move, remains the more reliable way to separate a genuine turnaround from a short-lived rally in this sector.

ALSO READ: Top 10 Penny Stocks in India

Factors to Consider Before Investing in Diagnostics and Pathology Labs Penny Stocks

• Debt levels: Several names on this list carry negative book values or high leverage, so check the debt-to-equity ratio before investing.
• Earnings consistency: Some diagnostics and pathology labs penny stocks are currently loss-making; track the trend in losses rather than the absolute number alone.
• Liquidity: Several small-cap and micro-cap names here trade with thin daily volumes, which can widen bid-ask spreads.
• Valuation versus earnings: Compare each stock's PE ratio against the sector PE to avoid overpaying for a re-rated stock.
• Sector cycle: Diagnostics and Pathology Labs companies are sensitive to sector-specific cycles, so track the relevant demand and pricing trends closely.

Benefits of Investing in Diagnostics and Pathology Labs Penny Stocks

• Low entry cost: Most diagnostics and pathology labs penny stocks trade below Rs 100, letting investors build a diversified position with a modest capital outlay.
• Sector exposure: These stocks offer exposure to the diagnostics and pathology labs sector without the capital outlay large-cap names require.
• Turnaround potential: Several names here are working through debt reduction or restructuring, which can offer upside if execution improves.
• Portfolio diversification: Adding a small allocation to this sector gives exposure to a theme distinct from banking, IT or FMCG-heavy portfolios.

Risks of Diagnostics and Pathology Labs Penny Stocks

• High volatility: Several stocks on this list can move sharply on thin volumes.
• Negative book values: More than one name here carries a negative book value, reflecting accumulated losses.
• Thin liquidity: Micro-cap names on this list see low daily trading volumes.
• Inconsistent earnings: Several diagnostics and pathology labs penny stocks here are currently loss-making or have very high PE ratios on thin earnings.

ALSO READ: Solar Penny Stocks in India

How to Choose the Right Diagnostics and Pathology Labs Penny Stock

• Prefer companies with lower debt-to-equity and a demonstrated revenue trend.
• Check ROE consistency over at least three years rather than a single strong quarter.
• Compare the company's PE ratio against the sector PE to avoid overpaying for a re-rated stock.
• Check trading volumes before entering or exiting a position, since several names here are thinly traded.

How to Invest in Diagnostics and Pathology Labs Penny Stocks

1. Screen diagnostics and pathology labs penny stocks by market cap, PE ratio and ROE using the Univest Screener.
2. Open a demat and trading account if you do not already have one.
3. Start with a small allocation, given how volatile these small-cap and micro-cap names can be.
4. Track quarterly results and sector-specific news rather than daily price moves.
5. Review your position periodically and rebalance if any single stock grows too large a share of your portfolio.

Conclusion

Diagnostics and pathology labs penny stocks in India 2027 sit at the intersection of a real sector story and the usual risks that come with low-priced, small-cap equities. Nephro Care India Ltd. stands out by market cap, while several of the smaller names here remain speculative turnaround bets. None of these should be treated as a core holding, and position sizing, debt checks and liquidity checks matter more here than the headline price.

ALSO READ: Green Energy Penny Stocks

FAQs

1. What are diagnostics and pathology labs penny stocks in India 2027?

Ans. These are shares of diagnostics and pathology labs sector companies trading at low absolute prices, generally under Rs 100. Nephro Care India Ltd., Sunil Healthcare Ltd., Modern Diagnostic and Research Centre Ltd., Star Imaging and Path Lab Ltd. and Invicta Diagnostic Ltd. are among the more actively tracked names.

2. Are diagnostics and pathology labs penny stocks a safe investment?

Ans. Diagnostics and Pathology Labs penny stocks carry high risk due to volatility, thin liquidity and, in several cases, negative book values or inconsistent earnings. They can deliver strong returns during sector upcycles but should form only a small part of a diversified portfolio.

3. Which are the best diagnostics and pathology labs penny stocks in India for 2027?

Ans. Based on current fundamentals, Nephro Care India Ltd. and Sunil Healthcare Ltd. carry the largest market caps on this list, while the smaller names carry higher risk profiles worth researching closely.

4. What is the market capitalisation of Nephro Care India Ltd.?

Ans. Nephro Care India Ltd. has a market capitalisation of approximately Rs 158.00 Cr, making it the largest name among the diagnostics and pathology labs penny stocks covered in this list.

5. How can I invest in diagnostics and pathology labs penny stocks?

Ans. You can invest in diagnostics and pathology labs penny stocks through any demat and trading account by screening companies on fundamentals such as PE ratio, ROE and debt-to-equity, and starting with a small allocation given the sector's volatility.

6. Should long-term investors buy these stocks now?

Ans. Long-term investors comfortable with high volatility may consider a small allocation to diagnostics and pathology labs penny stocks, but should consult a SEBI-registered financial advisor and review each company's debt and profitability before investing.